Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-16T20:26:15.899Z Has data issue: false hasContentIssue false

GERD is associated with the outcome of MDD treatment

Published online by Cambridge University Press:  23 March 2020

K. Matić
Affiliation:
Psychiatric hospital Sveti Ivan, psychiatric hospital Sveti Ivan, Zagreb, Croatia
I. Šimunović Filipčić
Affiliation:
University hospital center Zagreb, department of psychological medicine, Zagreb, Croatia
Ž. Bajić
Affiliation:
Biometrika healthcare research, Zagreb, Croatia
I. Filipčić
Affiliation:
Psychiatric hospital Sveti Ivan, psychiatric hospital Sveti Ivan, Zagreb, Croatia

Abstract

Introduction

Gastroesophageal reflux disease (GERD) is more prevalent among patients with major depressive disorder (MDD) than in general population, and vice versa. Bidirectional association of GERD and MDD is well documented. Although protective effect for gastric symptoms has been indicated for several antidepressants like trazodone, citalopram, fluoxetine, mirtazapine or fluvoxamine, these findings are sometimes contradictory. Similar may be claimed for antidepressive effect of some proton pump inhibitors. We decided to examine the association of GERD with the long-term efficacy of MDD treatment.

Objective

To examine the association of GERD and efficacy of MDD treatment.

Methods

This nested cross-sectional study was done during 2016 at Psychiatric hospital Sveti Ivan, Zagreb, Croatia on the sample of 1008 psychiatric patients. Key outcome was the number of psychiatric rehospitalizations since the first diagnosis of MDD. Predictor was patient-self-declared diagnosis of GERD. Covariates controlled by multivariate analysis of covariance were sex, age, duration of MDD in years, education, marital status, number of household members, work status, clinical global impression scale–severity of MDD at diagnosis, treatment with tricyclic antidepressants (TCA), selective serotonin reuptake inhbitors (SSRI), serotonin-norephinephrine reuptake inhibitors (SNRI), noradrenergic and specific serotonergic (NaSSA) and antipsychotics.

Results

MDD patients with GERD had significantly larger number of psychiatric rehospitalizations (mean = 5.4 (SD 6.82)) than MDD patients with no GERD (mean = 3.1 (SD 4.45)). After adjustment for all covariates, GERD significantly moderated the efficacy of treatment of MDD (P = 0.048; η2 = 0.05) (Figure 1).

Conclusion

To treat MDD effectively we should treat GERD as well.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster viewing: Comorbidity/dual pathologies
Copyright
Copyright © European Psychiatric Association 2017

Figure 1 Number of psychiatric rehospitalizations in patients with MDD and GERD; error bars represent 95% confidence intervals (n = 1008).

Figure 0

Figure 1 Number of psychiatric rehospitalizations in patients with MDD and GERD; error bars represent 95% confidence intervals (n = 1008).

Submit a response

Comments

No Comments have been published for this article.